imo NR *works* cycles of money on almost every OTC equity

New Post Public Reply Private Reply Replies (1) Message Board
4kids NickAidenNY #46880
643
imo NR *works* cycles of money on almost every OTC equity until they can't

so *imo* for years .. CTIX (IPIX) was taken UP and then reset back .. (this is why i watch *liquidity*) .. the last *take up* .. of significance *imo* .. was at the back end of 2014 (just under $5.00) .. with the handoff *imo* for the reset back down .. in early 2015 .. only a funny thing happened .. the company's platform was far stronger by 2015 .. and actual investors *imo* outweighed *traders* .. (this is why *imo* one of the signals to watch for is decreasing volume) .. but let's be clear and real .. most investors can have their emotions' triggered by a PPS relentlessly being compressed (and sell) .. however by July 2015 .. it was pretty clear to me (based on both *legal* reported and daily markage %s .. *increasing* .. that NR had a problem on their hands .. this is why i posted my first public post *there* on my NSS board .. that CTIX (IPIX) was about to blow wide open) .. because NR had few options .. when you can't get investors to part with their shares .. and *volume* BS *CONtinues* by rote .. NR will trigger reg sho (even on the poorly watched and blatantly bogus *reporting* that NR does on those OTC companies that came public via a R/M) .. and then came the classic playbook *attack* by NR .. which is played out by rote by NR

for those who've done the DD on NRs' *tactics* .. bogus BS is SOP
what kept me in my investment .. was mgmt's aggressive response back to the blatant fallacies' *orchestrated* by NR

company's diverse platform is huge .. but imo mgmt's *awareness* of what was being done then .. and how subsequently handled .. was actually more important to me .. having watched *clueless* mgmts on the OTC totally misunderstand NRs' attack and *intent* >> end result being loss of company besides a devastated PPS

usually what is being done is NR gets a stock so low .. mgmt is forced to do toxic financing .. this plays right into NRs' hands .. where they literally re-short
>> rinse and repeat <<

this is why some investors who know NRs' rigged game had concern about those 8M *shares* .. and why embeds are so threatened by daily % *marked*
because when there is *true* liquidity (whether by traders or investors' selling) daily markage doesn't *increase* .. it decreases .. and the exact opposite has happened on IPIX .. even more telling to me was what NR was *showing* on the *legal* they report to Finra (citing a bogus daily volume avg of 677k was also telling) .. for over a year now .. NR has had to keep a round robin of resets' *reported* (imo) on IPIX in the 1.1M - 1.2M *range* .. (imo everything NR does is % based) .. and why i strongly suspect NR is this close (an inch) to triggering reg sho

this is why it matters who NR utilizes as a decoy on l2 .. (MM Monthly also reported to Finra) .. there are only 3 MMs' that *matter* on IPIX .. for the past year + .. CDEL/NITE/ETRF .. so when you see *decoy* OTCX or VERT or any of the others *blocking* on l2 .. (bid or ask) .. odds are they are doing the *deed* for one of the first 3 reporting each month to Finra (per Finra .. only those MMs' actually doing the activity .. can report .. this is why for years i noted in posts that MMs can show what they want .. when they want .. but all actual activity (trades) had to be reported each month)

so volume avgs matter .. oddly enough at this point imo and noted previously .. PPS to me while important .. isn't per se .. because of how actual investors
have handled this last round of take down (70c to 35c) .. over the past year +

NR is battling *imo* a baby bio on the OTC with a diverse platform .. an aware mgmt team and as equally important *imo* >> more educated investors << than NR usually deals with on an OTC *target*

NR is used to controlling *outcomes* .. imo .. and while i'll never say never .. imo NRs' access to those 8M (imo approx half utilized so far) is more about trying to *control* news out of mgmt .. the more NR has to *access* in advance of mgmt's news .. the less ability NR has to *CONtroll* via embeds/crews working various SMBs

and imo that is the current dilemma NR is in .. sure they can reset the 52 week on their next goal of 30c/25c/20c/15c .. yada yada .. but then they face numerous investors who keep picking of *shares* .. NR really *cant* part with
and as i've noted numerous times .. decreasing volume avgs aligned with increasing daily %s .. and *a holding* pattern on *legal* reported .. COUNTERS SMB rhetoric about *sells* .. that is why it was so important to me to see what NR had to report re: *legal* over the past 6 to 8 weeks

my apologies on the delay of this response .. my time is limited these days due to family demands

best to all Innovation investors

4kids
Quote:

Is the overall synopsis that NR creates fake volume in order to drive price down and have retail sell shares for them to cover with?

The numbers show that they created all this commotion and only about 48,000 shares was cleared for them?

Also means that they are not doing a great job and retail investors are holding?



Thanks for the elaboration.

















Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 445

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading
Global Child Tests Purpose Travel's Expanding Media Reach

Updated Category News Views 45

Celebrity travel programming usually melts into the wallpaper, but Global Child is trying to make the scenery answer for itself. Its new season of Global Child “Travel & Purpose” puts Andrea Bocelli in Tuscany, Isabela Merced in Peru and John Malkovich in Croatia, while tying each destination to a broader local-good mission. That is a more thoughtful pitch than...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 607

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 191

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 137

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 410

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 731

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 126

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 530

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
Cardiovalve's Three-Year Data Clears a Crucial EU Hurdle

Updated Category News Views 98

A failing tricuspid valve is not a spreadsheet problem, and that matters before anybody gets carried away with a glossy conference presentation. Venus Medtech's Cardiovalve unit has reported results from TARGET in a population that was old, sick and largely out of good surgical options. That is precisely where a less invasive replacement therapy has to prove it can do...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring CRH Stock Performance Over Five Years and Beyond

Updated Category News Views 152

Understanding CRH's Impressive Growth CRH has displayed a remarkable performance in the stock market over the last five years, outshining many of its competitors with a 10.67% annualized return. This impressive growth translates to an average annual return of 23.49% for investors. Currently, CRH boasts a market capitalization of approximately $73.09 billion, making it a...

Continue Reading
Coordinated Care's Health Tour Expands Access Across WA

Updated Category News Views 78

A Grassroots Push for Health Equity Coordinated Care, a subsidiary of Centene Corporation, is hitting the road in Washington state. This isn't about just another healthcare campaign—you’ve got two vans, 'SeeMore' and 'Flossy', bringing essential vision and dental screenings right up to the folks who need them most. Taking Healthcare Directly to Communities Let's be...

Continue Reading
Italy's Antitrust Agency Investigates Snam-Edison Deal

Updated Category News Views 229

Investigation into the Snam and Edison Gas Storage Deal Italy's antitrust agency has recently initiated an investigation concerning the transaction between Snam and Edison involving Edison's gas storage unit. This move reflects the agency's commitment to maintaining healthy competition within the energy sector. Concerns Over Market Competition The Antitrust Authority,...

Continue Reading
Truist Financial Corporation's Quarterly Performance Insights

Updated Category News Views 240

Truist Financial's Results and Earnings Overview Truist Financial Corporation (TFC) announced its latest quarterly results, showcasing a robust financial performance that illustrates the company’s strategic focus on growth and stability. This release reflects the commitment of Truist to enhance the lives of its clients and communities by providing comprehensive...

Continue Reading
Investigation Into Possible Securities Fraud at UnitedHealth Group

Updated Category News Views 350

UnitedHealth Group Under Scrutiny for Securities Claims Ademi & Fruchter LLP has launched an investigation into potential securities fraud claims against UnitedHealth Group Incorporated (NYSE: UNH). This inquiry arises following inaccurate statements made by the company regarding its operational performance and future outlook. Investors and analysts alike express serious...

Continue Reading